<DOC>
<DOCNO>EP-0633928</DOCNO> 
<TEXT>
<INVENTION-TITLE>
MICRO-ORGANISMS, PREPARATION METHOD THEREFOR AND USES THEREOF
</INVENTION-TITLE>
<CLASSIFICATIONS>C12N120	C12R101	C12P2102	C12R129	C12N120	C07K1100	C12P2102	C07K1100	C12R1465	C12R104	C12P1718	C12P1718	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C12N	C12R	C12P	C12R	C12N	C07K	C12P	C07K	C12R	C12R	C12P	C12P	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C12N1	C12R1	C12P21	C12R1	C12N1	C07K11	C12P21	C07K11	C12R1	C12R1	C12P17	C12P17	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
<APPLICANT-NAME>
AVENTIS PHARMA SA
</APPLICANT-NAME>
<APPLICANT-NAME>
AVENTIS PHARMA S.A.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BARRERE GENEVIEVE
</INVENTOR-NAME>
<INVENTOR-NAME>
JUMEL CATHERINE
</INVENTOR-NAME>
<INVENTOR-NAME>
LACROIX PATRICIA
</INVENTOR-NAME>
<INVENTOR-NAME>
LEHMANN CORINNE
</INVENTOR-NAME>
<INVENTOR-NAME>
SABATIER ALAIN
</INVENTOR-NAME>
<INVENTOR-NAME>
BARRERE, GENEVIEVE
</INVENTOR-NAME>
<INVENTOR-NAME>
JUMEL, CATHERINE
</INVENTOR-NAME>
<INVENTOR-NAME>
LACROIX, PATRICIA
</INVENTOR-NAME>
<INVENTOR-NAME>
LEHMANN, CORINNE
</INVENTOR-NAME>
<INVENTOR-NAME>
SABATIER, ALAIN
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Microorganism capable of selectively producing the
streptogramin A or B components.
Microorganism according to Claim 1, 
characterized
in that
 it selectively produces the streptogramin A
component.
Microorganism according to Claim 1, 
characterized
in that
 it selectively produces the streptogramin B
component.
Microorganism according to one of Claims 1 to 3,

characterized in that
 the streptogramin is chosen from
the group consisting of pristinamycin, virginiamycin,

mikamycin, ostreogrycin, synergistin, viridogrisein,
vernamycin, plauracin, etamycin, griseoviridin,

neoviridogrisein and streptogramin.
Microorganism according to Claim 4, 
characterized
in that
 it selectively produces the streptrogramin A
component corresponding to the general formula shown in

Figure 1, in which Y represents a D-proline, a 4,5-dehydroproline,
a D-alanine or a D-cysteine, R0

represents a group C=O or CHOH, R1 is a hydrogen atom
or a methyl group, R2 is a hydrogen atom or a methyl

group and R3 is a methyl or isopropyl group. 
Microorganism according to Claim 4, 
characterized
in that
 it selectively produces the streptogramin B
component corresponding to the general formula shown in

Figure 2(a), in which Z represents an L-proline, an L-aspartic
acid, a pipecolic acid, a 4-oxopipecolic acid,

a 4-hydroxy-L-pipecolic acid or a 5-hydroxy-4-oxo-L-pipecolic
acid, R4 is a hydrogen atom or an amine of

formula NH(CH
3
) or N(CH
3
)
2
, R5 is a hydrogen atom or a
methyl group and R6 is a methyl or ethyl group.
Microorganism according to Claim 4, 
characterized
in that
 it selectively produces the streptogramin B
component corresponding to the general formula shown in

Figure 2(b), in which R7 represents a hydrogen atom or
a hydroxyl group and R8 represents a methyl or ethyl

group.
Microorganism according to Claim 4, 
characterized
in that
 the streptogramin is chosen from the group
consisting of pristinamycin, virginiamycin,

ostreogrycin and mikamycin.
Microorganism according to any one of Claims 1 to
8, 
characterized in that
 it is an Actinomycete or a
fungus.
Microorganism according to Claim 9, 
characterized
in that
 it is a Streptomyces.
The strains S. pristinaespiralis No. CBS 182.92
and CBS 183.92; S. ostreogriseus No. CBS 142.93 and

143.93; and S. virginiae No. CBS 140.93 and 141.93.
Method for preparing a microorganism as defined in
any one of the preceding claims, 
characterized in that

the following steps are carried out:

in an optional first step, mutagenesis is
carried out on a non-selective streptogramin-producing

microorganism, and 
in a second step, the selective microorganisms are
selected.
Method according to Claim 12, 
characterized in
that
 the non-selective streptogramin-producing
microorganism is chosen from actinomycetes and fungi.
Method according to Claim 13, 
characterized in
that
 the microorganism is a microorganism which is a
non-selective producer of a streptogramin chosen from

the group consisting of pristinamycin, virginiamycin,
mikamycin, ostreogrycin, synergistin, viridogrisein,

vernamycin, plauracin, etamycin, griseoviridin,
neoviridogrisein and streptogramin.
Method according to Claim 14, 
characterized in
that
 the microorganism is chosen from Streptomyces
alborectus, Streptomyces diastaticus, Streptomyces

graminofaciens, Streptomyces griseus, Streptomyces
loidensis, Streptomyces mitakaensis, Streptomyces

olivaceus, Streptomyces ostreogriseus, Streptomyces
pristinaespiralis, Streptomyces virginiae, Streptomyces

lavendulae, Streptomyces griseoviridus, Micromonospora
sp., Actinomyces auranticolor, Actinomyces

daghestanicus and Actinomyces azureus.
Method according to one of Claims 12 to 15,

characterized in that
 the mutagenesis step is carried
out by chemical and/or physical and/or genetic

treatment of the microorganism.
Method according to one of Claims 12 to 15,

characterized in that
 the selection step is carried out
using a test for sensitivity with respect to a

microorganism, using an ELISA assay by means of
antibodies specific for the A or B components, or else

using analytical techniques such as chromatography. 
Method according to Claim 17, 
characterized in
that
 the selection step is carried out using a test for
sensitivity with respect to a microorganism, followed

by chromatographic assaying.
Method for preparing one of the streptogramin A or
B components, 
characterized in that
 a microorganism
according to any one of Claims 1 to 11 i
s cultured
under production conditions, and the component produced

is recovered.
Method according to Claim 19, for preparing a
macrolactone of general formula represented in Figure

1, in which the substituents have the same meaning as
in Claim 5, or a mixture of such macrolactones,


characterized in that
 a specific microorganism
according to Claim 2 is cultured, and the products

obtained are separated from the culture medium.
Method according to Claim 19, for preparing a
depsipeptide of general formula represented in Figure

2(a), in which the substituents have the same meaning
as in Claim 6, or a mixture of such depsipeptides,


characterized in that
 a specific microorganism
according to Claim 3 is cultured, and the products

obtained are separated from the culture medium.
Use of the streptogramin A and B components
obtained according to the method of one of Claims 12 to

21, for producing hemisynthetic derivatives.
</CLAIMS>
</TEXT>
</DOC>
